Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies

MeSH terms

• Adult
• Aged
• Allografts
• Busulfan* / administration & dosage
• Busulfan* / analogs & derivatives
• Busulfan* / therapeutic use
• Female
• Hematopoietic Stem Cell Transplantation* / methods
• Humans
• Male
• Middle Aged
• Recurrence
• Retrospective Studies
• Survival Rate
• Transplantation Conditioning* / methods
• Transplantation, Homologous / methods
• Vidarabine* / administration & dosage
• Vidarabine* / analogs & derivatives
• Vidarabine* / therapeutic use